Stock listing

Roivant Sciences Ltd.

Selected listing: 87S · GETTEX · EUR · DE

Roivant Sciences Ltd. (gettex:87S), Health Technology. Latest release Sep 23, 2026: Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402…

87S:GETTEXEURDEUpdated October 2, 2026

Ticker: gettex:87S
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: gettex
Currency: EUR

Latest news from Roivant Sciences Ltd.

Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus

September 23, 2026

Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study

September 8, 2026

Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call

September 6, 2026

Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026

September 6, 2026

Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

August 27, 2026

All Roivant Sciences Ltd. news →

Events

Replays

Roivant Sciences Ltd. (ROIV) Q1 2026 Earnings Call
Thu, Aug 06, 2026 · 08:00 AM ET
Watch
Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call
Wed, May 20, 2026 · 08:00 AM ET
Watch
Roivant Sciences Ltd. (ROIV) Q3 2025 Earnings Call
Fri, Feb 06, 2026 · 08:00 AM ET
Watch

Research Roivant Sciences Ltd.

Roivant Sciences Ltd. company profile

View the public company page for Roivant Sciences Ltd. on 6ix.

Roivant Sciences Ltd. news

Read company news and market updates connected to Roivant Sciences Ltd..

Roivant Sciences Ltd. investor events

Find investor webinars, events, and replay context for Roivant Sciences Ltd..